BRNS
Price
$1.24
Change
-$0.04 (-3.12%)
Updated
Aug 15, 04:29 PM (EDT)
Capitalization
50.49M
82 days until earnings call
SLNO
Price
$71.62
Change
-$5.74 (-7.42%)
Updated
Aug 15, 04:59 PM (EDT)
Capitalization
3.81B
81 days until earnings call
Interact to see
Advertisement

BRNS vs SLNO

Header iconBRNS vs SLNO Comparison
Open Charts BRNS vs SLNOBanner chart's image
Barinthus Biotherapeutics
Price$1.24
Change-$0.04 (-3.12%)
Volume$200
Capitalization50.49M
Soleno Therapeutics
Price$71.62
Change-$5.74 (-7.42%)
Volume$70.59K
Capitalization3.81B
BRNS vs SLNO Comparison Chart in %
Loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRNS vs. SLNO commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a Hold and SLNO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (BRNS: $1.24 vs. SLNO: $71.63)
Brand notoriety: BRNS and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 1% vs. SLNO: 505%
Market capitalization -- BRNS: $50.49M vs. SLNO: $3.81B
BRNS [@Biotechnology] is valued at $50.49M. SLNO’s [@Biotechnology] market capitalization is $3.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, BRNS is a better buy in the long-term than SLNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 5 TA indicator(s) are bullish while SLNO’s TA Score has 3 bullish TA indicator(s).

  • BRNS’s TA Score: 5 bullish, 5 bearish.
  • SLNO’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, BRNS is a better buy in the short-term than SLNO.

Price Growth

BRNS (@Biotechnology) experienced а -7.46% price change this week, while SLNO (@Biotechnology) price change was -13.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

BRNS is expected to report earnings on Nov 06, 2025.

SLNO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($3.81B) has a higher market cap than BRNS($50.5M). SLNO YTD gains are higher at: 59.355 vs. BRNS (2.649). BRNS has higher annual earnings (EBITDA): -58.89M vs. SLNO (-194.63M). SLNO has more cash in the bank: 290M vs. BRNS (99.1M). BRNS has less debt than SLNO: BRNS (11.9M) vs SLNO (52.8M). BRNS has higher revenues than SLNO: BRNS (15M) vs SLNO (0).
BRNSSLNOBRNS / SLNO
Capitalization50.5M3.81B1%
EBITDA-58.89M-194.63M30%
Gain YTD2.64959.3554%
P/E RatioN/AN/A-
Revenue15M0-
Total Cash99.1M290M34%
Total Debt11.9M52.8M23%
FUNDAMENTALS RATINGS
SLNO: Fundamental Ratings
SLNO
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
44
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRNSSLNO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 5 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 5 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSXCX27.51N/A
N/A
abrdn US Small Cap Equity C
MCVCX10.99N/A
N/A
Transamerica Mid Cap Value Opps C
ESCFX15.11N/A
N/A
1290 Essex Small Cap Growth A
MIEKX39.73N/A
N/A
MFS International Equity I
CGIIX50.84-0.12
-0.24%
Calamos Growth & Income I

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with SLNO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
-2.81%
SLNO - BRNS
56%
Loosely correlated
-7.41%
NGNE - BRNS
51%
Loosely correlated
+1.53%
NEUP - BRNS
50%
Loosely correlated
N/A
IMVT - BRNS
48%
Loosely correlated
+0.13%
TARA - BRNS
35%
Loosely correlated
-5.02%
More